P3 Health Partners (PIIIW) EBITDA (2021 - 2025)

P3 Health Partners (PIIIW) has 5 years of EBITDA data on file, last reported at -$153.4 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA fell 11.29% year-over-year to -$153.4 million; the trailing twelve-month figure through Dec 2025 stood at -$268.1 million (up 15.76% YoY), and the FY2025 full-year result was -$268.1 million, up 15.76% from the prior year.
• EBITDA for Q4 2025 stood at -$153.4 million, down from -$43.7 million in the prior quarter.
• Across five years, EBITDA topped out at $564.4 million in Q4 2021 and bottomed at -$911.6 million in Q2 2022.
• The 5-year median for EBITDA is -$43.5 million (2024), against an average of -$90.6 million.
• The widest annual swing landed in 2022, when EBITDA tumbled 3410.01%; it then surged 97.76% in 2023.
• A 5-year view of EBITDA shows it stood at $564.4 million in 2021, then sank by 194.96% to -$535.9 million in 2022, then soared by 88.1% to -$63.8 million in 2023, then tumbled by 116.13% to -$137.8 million in 2024, then fell by 11.29% to -$153.4 million in 2025.
• The last three EBITDA figures came in at -$153.4 million (Q4 2025), -$43.7 million (Q3 2025), and -$33.5 million (Q2 2025), per Business Quant data.

Peer Comparison